Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2663002016 | Haemophilus influenzae type b 7.5micrograms/recombinant hepatitis B virus surface antigen 5micrograms injection solution 0.5mL vial (product) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
2674870017 | Haemophilus influenzae type b 7.5micrograms/recombinant hepatitis B virus surface antigen 5micrograms injection solution 0.5mL vial | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
368951000077115 | flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant | Is a | Hib-HB Haemophilus influenzae de type B + hépatite B pédiatrique non spécifié | false | Inferred relationship | Some | ||
flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | vaccin recombinant contre le virus de l'hépatite B | false | Inferred relationship | Some | ||
flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | vaccin contre Haemophilus influenzae de type B | false | Inferred relationship | Some | ||
flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant | Has manufactured dose form | injection | false | Inferred relationship | Some | ||
flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant | Has manufactured dose form | Solution for injection | false | Inferred relationship | Some | ||
flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | vaccin contre Haemophilus influenzae de type B | false | Inferred relationship | Some | 2 | |
flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | vaccin recombinant contre le virus de l'hépatite B | false | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)